Junji Bio

Suzhou, China · Founded 2020 · Privately Held (backing)

Developer of biosynthesis designed to provide overall solutions for molecular diagnosis, nucleic acid chemistry, synthetic biology and antibody drug development. Junji Bio is based in Suzhou, China and was founded in 2020. It has raised $14.1 million.

Last price · $/share
—
Implied valuation
—
Total raised
$14.1M
Last round
—

Who backs Junji Bio?

5 investors
InvestorType
Hangzhou Dongfang Jiafu Asset ManagementOther
Optics Valley Industry InvestmentGrowth equity
Lianyungang Jinhai Venture CapitalOther
Jiangsu Jinqiao Private Equity Fund Management—
Tenyall Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Junji Bio investors

5 investors are on record for Junji Bio, including Hangzhou Dongfang Jiafu Asset Management, Optics Valley Industry Investment, Lianyungang Jinhai Venture Capital and Jiangsu Jinqiao Private Equity Fund Management.

Free account
More of Junji Bio with a free account
  • ·Watch Junji Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Junji Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View